Korea

Health On Cloud Showcases Innovative Healthcare Solutions at the Korea-LAC Trade and Innovation Forum, Accelerating Expansion into Latin America

SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Health On Cloud (HOC) is impactingColombia's healthcare sector through the use of digital innovations in a pilot project funded by the Inter-American Development Bank (IDB). This initiative is scheduled to expand toMexico and Brazil in the first ha...

2024-12-02 22:00 2114

COSRX Unveils The New Advanced Snail Mucin Glass Glow Hydrogel Mask

NEW YORK, Dec. 1, 2024 /PRNewswire/ -- Viral K-Beauty brand, COSRX launches theAdvanced Snail Mucin Glass Glow Hydrogel Mask

2024-12-02 09:19 2316

Global Focus INC-5 Conference: Niutech Demonstrates 10,000-ton Continuous Plastic Pyrolysis Technology and Complete Equipment

JINAN, China, Nov. 30, 2024 /PRNewswire/ -- From November 25th to December 1st, 2024, the fifth session of the Intergovernmental Negotiating Committee on Plastic Pollution (INC-5) has been held in the Busan Exhibition & Convention Center inSouth Korea. Over 1400 negotiators from 178 member states...

2024-12-02 08:45 2100

DEEP FINE wins at CES Innovation Awards 2025 with XR spatial information construction solution DSC

- DEEP FINE wins CES Innovation Award in the XR Technology & Accessories Category and Gears Up for January Exhibition - DSC can create real spaces in 3D without expensive equipment or personnel, can even create and deploy AR content - "Building digital twins with DSC can cut costs by up to 80%. ...

2024-11-29 21:00 2822

Hankyung.com introduces: JMsys, Development of an outdoor app that provides voice guidance even on mountain trails

SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- JMsys is a company that developed the industry's first blockchain-based mountain trail voice guidance platform. It has been recognized for its technological prowess by the Ministry of Science and ICT and has been selected as a blockchain expansion...

2024-11-28 21:00 2539

Fintica AI and Legend Arb of Hong Kong Announce Strategic Investment and Partnership

HONG KONG, Nov. 27, 2024 /PRNewswire/ -- Fintica AI Ltd, a leading innovator in next-generation AI solutions for capital markets, and Legend Arb Trading Limited, aHong Kong-based proprietary trading firm with a global footprint across major financial hubs such asShanghai, Taiwan, and Singapore, h...

2024-11-28 09:00 2421

Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging

* AI-powered chest X-ray and mammography analysis solutions to be deployed across one ofMexico's largest healthcare networks SEOUL, South Korea, Nov. 27, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announc...

2024-11-27 22:00 2447

Hankyung.com introduces: A noteworthy Korean vegan skincare brand: ASNO lifts off in US market through Amazon

SEOUL, South Korea, Nov. 27, 2024 /PRNewswire/ -- ASNO is a vegan beauty brand which has a concept of protecting animals in Arctic andAntarctica, which are endangered due to environmental pollution.Its products formulated with non-irritating, natural, vegan and active ingredients. They are free o...

2024-11-27 21:00 2263

Award-Winning CMUH (Taiwan) Excels at HIMSS, Leading Taiwan's Smart Healthcare Transformation

TAICHUNG, Nov. 27, 2024 /PRNewswire/ -- In HIMSS24 APAC Seoul, Healthcare Conference & Exhibition, China Medical University Hospital (CMUH) established international presence with four notable gradings: achieving the top score in the 2023 HIMSS Global Digital Health Indicator (DHI) and receiving ...

2024-11-27 21:00 2307

SK hynix Announces 25% Hike in Dividend in New Shareholder Return Program

* Annual fixed dividend to rise 25% to 1,500 won a share, according to shareholder return program for 2025-27 * Separate "Value Up" plan stipulates capex discipline to maintain scale of investment at appropriate level * New plans aimed at bringing shareholder a return that matches company's ...

2024-11-27 18:13 2845

Dot and Microsoft Unveil 'Dot Vista': A Breakthrough AI Image Conversion Solution for Accessibility

* Dot Unveils DotVista, the NPU-powered app on Windows 11 Copilot+ PCs for the Visually Impaired, with Microsoft andHanyang University at Microsoft Ignite  * DotVista is set to debut first on Windows 11 via the Microsoft Store in the second quarter of 2025, including the Accessible Zoo and Frui...

2024-11-26 22:00 2749

Hankyung.com introduces: ES Technology, the only domestic manufacturer of electric lift, increase the efficiency of specialized equipment such as medical devices and cooperative robots

SEOUL, South Korea, Nov. 26, 2024 /PRNewswire/ -- It is a company that presents ergonomic systems to the industry with the vision of "a company that pursues a convenient life for mankind through automation." Based on more than 24 years of accumulated experience and know-how, it is the only electr...

2024-11-26 21:00 2285

Hygenco selects Danish company Topsoe as Licensor for its Green Ammonia Plant

GURUGRAM, India, Nov. 26, 2024 /PRNewswire/ -- Hygenco Green Energies, a pioneer in low-cost green hydrogen production, has announced a partnership with Denmark-based Topsoe, a leading global technology provider for the energy transition, as the licensor for its green ammonia plant in Gopalpur, Od...

2024-11-26 10:00 2083

GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

YONGIN, South Korea, Nov. 25, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A (MPS IIIA). GC Biopharma and Novel Pharma have...

2024-11-26 08:44 2247

Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with 'Neurophet AQUA'

* New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy analysis * Accelerating global expansion with cutting-edge technology targeting MS, a prevalent condition inNorth America and Europe. SEOUL, South Korea, Nov. 25, 2024...

2024-11-25 22:00 2067

Korea Innovation Foundation selects 3 Innovative Energy companies, BK Energy, BA Energy, and VINATech for Global Technology Commercialization Support Program (North America)

Powering the Future: Innovative Energy Solutions from Korea NEW YORK and SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- The Korea Innovation Foundation (INNOPOLIS), currently operating the 2024 Global Technology Commercialization Support Program (North America), announces that 3 innovative en...

2024-11-25 22:00 3353

Visualsyn's Glinda AIMI Recognized with CES Innovation Award 2025

Streamlined workflows on AI-powered 3D content creation platform make XR accessible, affordable, and scalable for businesses of all sizes LAS VEGAS and SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Visualsyn , a Korean XR production startup, announced today that it...

2024-11-25 22:00 2132

Hankyung.com introduces: RGT Accelerates Global Expansion of SIRBOT targeting North America, Europe, and Emerging Markets

SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- RGT (Robot Global Team), a leading South Korean service robotics solutions company, has initiated a significant global market expansion with its AI-driven autonomous serving robot, SIRBOT. In a global serving robot market predominantly occupied by...

2024-11-25 21:00 1601

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease

* HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. * No serious treatment related adverse events were reported and such findings were proportional between placebo and dosed groups. * PK results support once a day dosing. ROCKVILLE, Md. and SEOUL,...

2024-11-25 20:00 1943

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S. Phase 1 trial is progressing smoothly, with no dose-limiting toxicity observed Phase 1 trial evaluating the combination of BH3120 and MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) un...

2024-11-25 09:30 2140
1 ... 35363738394041 ... 132